Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:50:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase II open-label study of nivolumab combined with ipilimumab and bicalutamide for HER2-negative metastatic or unresectable breast cancer, with changes in the study's collaborators and revision number. The previous goal of the protocol has been removed, indicating a shift in focus.
    Difference
    50%
    Check dated 2025-04-16T01:46:08.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, indicating a new release. Additionally, a date has been added, which may signify an important upcoming event or deadline.
    Difference
    0.2%
    Check dated 2025-04-08T20:22:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The webpage has updated its date-related content, removing several past dates and adding new future dates, indicating a shift in the timeline of events or availability.
    Difference
    0.8%
    Check dated 2025-03-10T23:48:19.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:12:09.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:25:08.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.